SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about e-voting results

13 Jul 2021 Evaluate
In continuation of letter dated 12th July, 2021 regarding proceeding of 29th Annual General Meeting ('AGM') of Welcure Drugs & Pharmaceuticals held on Monday, 12th July, 2021 at 10:00 AM through Video Conferencing/ other audio visual means, Welcure Drugs & Pharmaceuticals has informed that it enclosed the voting results (for E-Voting) along with the Scrutinizer's Report, as per the provision of Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

0.32 0.01 (3.23%)
21-Apr-2026 11:35 View Price Chart
Peers
Company Name CMP
Redington 228.90
Adani Enterprises 2231.00
Amrapali Industries 17.40
Rashi Peripheral 475.00
PDS 297.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×